Fremont, CA – Personalis Inc. has announced the appointment of Richard Chen as President. About Personalis Inc.: Personalis Inc. is revolutionizing cancer care through its expertise in advanced testing, cancer genomics, and data science, focusing on transforming the active management of cancer with next-generation sequencing (NGS)-based technologies and molecular profiling platforms. The company operates key business segments including pharma tests and services for clinical trials and drug development, enterprise sales of tumor profiling and diagnostic tests, and population sequencing services such as those provided to the Department of Veterans Affairs Million Veteran Program. Its flagship NeXT molecular profiling platform analyzes up to 20,000 human genes from a single sample, offering a comprehensive view of a patients immune system and enabling highly sensitive detection of minimum residual disease (MRD) and early recurrence using proprietary algorithms combined with tumor-and-normal profiling. Founded in 2011 and headquartered in Fremont, California, Personalis holds a strong market position as a public U.S. company with 229 employees and $84.6 million in revenue for 2024, delivering cutting-edge insights to improve biomarker strategies and personalized treatments.

For more information on Personalis Inc. please visit: https://www.personalis.com/

Personalis Inc.
6600 Dumbarton Circle
Fremont, CA 94555
Phone: 855-436-6634
LinkedIn Page: https://www.linkedin.com/company/personalis-inc/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved